Lv11
20 积分 2024-03-06 加入
Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial
2小时前
待确认
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2小时前
已完结
Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial
3小时前
已完结
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study
3小时前
已完结
Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer
9个月前
已完结
Personalized mRNA Vaccine Immunogenic against PDAC
9个月前
已完结
Predicting Organizational Mortality: How Financial Management Matters
10个月前
已完结
Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1
10个月前
已完结
T-Cell Immunotherapy against Mutant KRAS for Pancreatic Cancer
10个月前
已完结
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial
11个月前
已完结
p‐ and n‐Type Bipolar Redox‐Active Radical Polymer: Toward Totally Organic Polymer‐Based Rechargeable Devices with Variable Configuration
皖公网安备34019202002308
